Biopreservation
One of the benefits of cryopreserving cells is the flexibility in scheduling for later use that freezing provides. Determining the optimal solution for cryopreservation that consistently results in post-thaw recovery of the greatest number of highly viable, functional cells is crucial. The article by Sara S. Parker et al. published in eNeuro and recently added […]
BioLife Solutions Announces Third Quarter 2018 Financial Results
Revenue increases 79% to a record $5.3 million; achieves net income of $1.2 million On November 8, 2018, BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary biopreservation media products for cell and gene therapies, reported financial results and operational highlights for the three and nine months ended September 30, 2018. Revenue […]
New GE Life Sciences NK Cell White Paper Citing CryoStor
GE Life Sciences recently published the white paper “Workflow for primary human NK cell isolation, xeno-free expansion, harvest, and cryopreservation.” In it, they detail how challenging it is to obtain primary human NK cells at clinically relevant scale, and outline methods for workflow optimization and cryopreservation, utilizing CryoStor CS 10. For additional details or to […]
BioPreservation Blog 8/8/2018
The number of applications for BioLife Solutions’ biopreservation reagents continues to grow, and we are pleased to highlight these newest citations: Habiel, D., Espindola, M., Coelho, A., & Hogaboam, C. Modeling Idiopathic Pulmonary Fibrosis in Humanized SCID Mice. The American Journal of Pathology 2018 Apr; 188(4): 891-903. doi: 10.1016/j.ajpath.2017.12.020 Habiel et. al. provided detailed methods for the creation […]
Our New White Paper on The Importance of Collection, Processing and Biopreservation Best Practices in Determining CAR-T Starting Material Quality
BioLife recently partnered with HemaCare and BioInsights to create our latest Biopreservation Best Practices White Paper. See for yourself how critical starting material quality is for CAR-T and other cell manufacturing and learn how to best optimize your biopreservation methods to follow best practices.
BioLife Solutions to Present at the 2018 BIO International Convention
BioLife Solutions Inc. today announced that Michael Rice, CEO, and Roderick de Greef, CFO, will be attending and presenting at the 2018 BIO International Convention, June 4 – 7, 2018, at the Boston Convention and Exhibition Center. The corporate presentation is scheduled at 4:30PM on Monday, June 4th in theater 4. Investor and partner attendees interested to meet […]
SAVSU Technologies Announces Major evo.is® Cold Chain SaaS Update and New evo® Extreme Product Line for Shipping Cell Therapies
evo System Adopted by Leading Specialty Logistics Service Providers and Cell Therapy Manufacturers as Best Practice On May 2, 2018, our Joint Venture partner, SAVSU Technologies, the leading developer of smart precision shipping containers and cloud-based cold chain management SaaS solutions, announced two major upgrades to its industry best evo system; including enhanced software and shipping […]
BioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% Sequentially 2018 Revenue Guidance Revised Upward
On April 2, 2018, BioLife Solutions Inc. (NASDAQ: BLFS) (“BioLife”), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, announced preliminary revenue for the three months ended March 31, 2018. First quarter 2018 preliminary revenue from sales of BioLife’s proprietary CryoStor® and HypoThermosol® biopreservation media products reached $3.8 million, […]
BioLife Solutions and SAVSU Technologies to be Awarded Second Patent for Next Generation Cold Chain Technologies Designed for Cell and Gene Therapies
12 Additional Pending Patent Applications Submitted for evo® Smart Shippers, Liquid Nitrogen Dry Vapor Shippers and Cold Chain SaaS Application On March 26, 2018 BioLife Solutions Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, and SAVSU Technologies, the leading developer of smart, […]
PDA Presentation: Cell Viability After Cryopreservation
On March 20, 2018 Dr. Brian Hawkins, Scientific Applications Director, will be presenting a poster entitled, “The prats and pitfalls of assessing cell viability after cryopreservation,” at the 2018 PDA Annual Meeting in Orlando, FL. The poster describes how common methods of determining cell viability under normal conditions are inconsistent and inaccurately represent cell health […]